Checkpoint kinase 1 negatively regulates somatic hypermutation

Nucleic Acids Research

Volumn 42, Issue 6, 2014, Pages 3666-3674

  Frankenberger, Samantha ^a,b   Davari, Kathrin ^b   Fischer Burkart, Sabine ^a   Böttcher, Katrin ^b   Tomi, Nils Sebastian ^b   Zimber Strobl, Ursula ^a   Jungnickel, Berit ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; DNA REPAIR; HUMANS; MICE; MICE, INBRED C57BL; PROTEIN KINASES; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 84898969703     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1378     Document Type: Article

References (40)

1. Branzei, D. and Foiani, M. (2008) Regulation of DNA repair throughout the cell cycle. Nat. Rev. Mol. Cell Biol., 9, 297-308.
2. Warmerdam, D. O. and Kanaar, R. (2010) Dealing with DNA damage: relationships between checkpoint and repair pathways. Mutat. Res., 704, 2-11.
3. Callen, E., Nussenzweig, M. C. and Nussenzweig, A. (2007) Breaking down cell cycle checkpoints and DNA repair during antigen receptor gene assembly. Oncogene, 26, 7759-7764.
4. Stracker, T. H., Usui, T. and Petrini, J. H. (2009) Taking the time to make important decisions: the checkpoint effector kinases Chk1 and Chk2 and the DNA damage response. DNA Repair (Amst.), 8, 1047-1054.
5. Di Noia, J. M. and Neuberger, M. S. (2007) Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem., 76, 1-22.
6. Pavri, R., Gazumyan, A., Jankovic, M., Di Virgilio, M., Klein, I., Ansarah-Sobrinho, C., Resch, W., Yamane, A., Reina San-Martin, B., Barreto, V. et al. (2010) Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell, 143, 122-133.
7. Bransteitter, R., Pham, P., Scharff, M. D. and Goodman, M. F. (2003) Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc. Natl Acad. Sci. USA, 100, 4102-4107.
8. Langerak, P., Nygren, A. O., Krijger, P. H., van den Berk, P. C. and Jacobs, H. (2007) A/T mutagenesis in hypermutated immunoglobulin genes strongly depends on PCNAK164 modification. J. Exp. Med., 204, 1989-1998.
9. Zeng, X., Winter, D. B., Kasmer, C., Kraemer, K. H., Lehmann, A. R. and Gearhart, P. J. (2001) DNA polymerase eta is an A-T mutator in somatic hypermutation of immunoglobulin variable genes. Nat. Immunol., 2, 537-541.
10. Liu, M., Duke, J. L., Richter, D. J., Vinuesa, C. G., Goodnow, C. C., Kleinstein, S. H. and Schatz, D. G. (2008) Two levels of protection for the B cell genome during somatic hypermutation. Nature, 451, 841-845.
11. Phan, R. T. and Dalla-Favera, R. (2004) The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature, 432, 635-639.
12. Phan, R. T., Saito, M., Basso, K., Niu, H. and Dalla-Favera, R. (2005) BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells. Nat. Immunol., 6, 1054-1060.
13. Ranuncolo, S. M., Polo, J. M., Dierov, J., Singer, M., Kuo, T., Greally, J., Green, R., Carroll, M. and Melnick, A. (2007) Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNAdamage sensor AT R. Nat. Immunol., 8, 705-714.
14. Ranuncolo, S. M., Polo, J. M. and Melnick, A. (2008) BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells. Blood Cells Mol. Dis., 41, 95-99.
15. Zachos, G., Rainey, M. D. and Gillespie, D. A. (2003) Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects. EMBO J., 22, 713-723.
16. Arakawa, H., Lodygin, D. and Buerstedde, J. M. (2001) Mutant loxP vectors for selectable marker recycle and conditional knock-outs. BMC Biotechnol., 1, 7.
17. Scheller, H., Tobollik, S., Kutzera, A., Eder, M., Unterlehberg, J., Pfeil, I. and Jungnickel, B. (2010) c-Myc overexpression promotes a germinal center-like program in Burkitt's lymphoma. Oncogene, 29, 888-897.
18. Zhao, B., Bower, M. J., McDevitt, P. J., Zhao, H., Davis, S. T., Johanson, K. O., Green, S. M., Concha, N. O. and Zhou, B. B. (2002) Structural basis for Chk1 inhibition by UCN-01. J. Biol. Chem., 277, 46609-46615.
19. Teng, M., Zhu, J., Johnson, M. D., Chen, P., Kornmann, J., Chen, E., Blasina, A., Register, J., Anderes, K., Rogers, C. et al. (2007) Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors. J. Med. Chem., 50, 5253-5256.
20. Sato, S., Fujita, N. and Tsuruo, T. (2002) Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine). Oncogene, 21, 1727-1738.
21. Sale, J. E. and Neuberger, M. S. (1998) TdT-accessible breaks are scattered over the immunoglobulin V domain in a constitutively hypermutating B cell line. Immunity, 9, 859-869.
22. Maccarthy, T., Roa, S., Scharff, M. D. and Bergman, A. (2009) SHMTool: a webserver for comparative analysis of somatic hypermutation datasets. DNA Repair (Amst.), 8, 137-141.
23. Sale, J. E., Calandrini, D. M., Takata, M., Takeda, S. and Neuberger, M. S. (2001) Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature, 412, 921-926.
24. Reynaud, C. A., Anquez, V., Grimal, H. and Weill, J. C. (1987) A hyperconversion mechanism generates the chicken light chain preimmune repertoire. Cell, 48, 379-388.
25. Ruckerl, F., Busse, B. and Bachl, J. (2006) Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines. Mol. Immunol., 43, 1645-1652.
26. Wu, X., Tschumper, R. C., Gutierrez, A. J., Mihalcik, S. A., Nowakowski, G. S. and Jelinek, D. F. (2010) Selective induction of DNA repair pathways in human B cells activated by CD4+T cells. PLoS One, 5, e15549.
27. Takai, H., Tominaga, K., Motoyama, N., Minamishima, Y. A., Nagahama, H., Tsukiyama, T., Ikeda, K., Nakayama, K., Nakanishi, M. and Nakayama, K. (2000) Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev., 14, 1439-1447.
28. Arakawa, H., Saribasak, H. and Buerstedde, J. M. (2004) Activationinduced cytidine deaminase initiates immunoglobulin gene conversion and hypermutation by a common intermediate. PLoS Biol., 2, E179.
29. Lam, M. H., Liu, Q., Elledge, S. J. and Rosen, J. M. (2004) Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell, 6, 45-59.
30. Di Noia, J. and Neuberger, M. S. (2002) Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature, 419, 43-48.
31. Arakawa, H., Hauschild, J. and Buerstedde, J. M. (2002) Requirement of the activation-induced deaminase (AID) gene for immunoglobulin gene conversion. Science, 295, 1301-1306.
32. Hasham, M. G., Donghia, N. M., Coffey, E., Maynard, J., Snow, K. J., Ames, J., Wilpan, R. Y., He, Y., King, B. L. and Mills, K. D. (2010) Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination. Nat. Immunol., 11, 820-826.
33. Gourzi, P., Leonova, T. and Papavasiliou, F. N. (2006) A role for activation-induced cytidine deaminase in the host response against a transforming retrovirus. Immunity, 24, 779-786.
34. Sorensen, C. S., Hansen, L. T., Dziegielewski, J., Syljuasen, R. G., Lundin, C., Bartek, J. and Helleday, T. (2005) The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat. Cell. Biol., 7, 195-201.
35. Bahassi, E. M., Ovesen, J. L., Riesenberg, A. L., Bernstein, W. Z., Hasty, P. E. and Stambrook, P. J. (2008) The checkpoint kinases Chk1 and Chk2 regulate the functional associations between hBRCA2 and Rad51 in response to DNA damage. Oncogene, 27, 3977-3985.
36. Takao, N., Kato, H., Mori, R., Morrison, C., Sonada, E., Sun, X., Shimizu, H., Yoshioka, K., Takeda, S. and Yamamoto, K. (1999) Disruption of ATM in p53-null cells causes multiple functional abnormalities in cellular response to ionizing radiation. Oncogene, 18, 7002-7009.
37. Wang, W., Seki, M., Otsuki, M., Tada, S., Takao, N., Yamamoto, K., Hayashi, M., Honma, M. and Enomoto, T. (2004) The absence of a functional relationship between ATM and BLM, the components of BASC, in DT40 cells. Biochim. Biophys. Acta, 1688, 137-144.
38. Yamamoto, K., Ishiai, M., Matsushita, N., Arakawa, H., Lamerdin, J. E., Buerstedde, J. M., Tanimoto, M., Harada, M., Thompson, L. H. and Takata, M. (2003) Fanconi anemia FANCG protein in mitigating radiation-and enzyme-induced DNA doublestrand breaks by homologous recombination in vertebrate cells. Mol. Cell. Biol., 23, 5421-5430.
39. Neiman, P. E., Burnside, J., Elsaesser, K., Hwang, H., Clurman, B. E., Kimmel, R. and Delrow, J. (2006) Analysis of gene expression, copy number and palindrome formation with a Dt40 enriched cDNA microarray. Subcell. Biochem., 40, 245-256.
40. Pasqualucci, L., Neumeister, P., Goossens, T., Nanjangud, G., Chaganti, R. S., Kuppers, R. and Dalla-Favera, R. (2001) Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature, 412, 341-346.